The impact of pharmacovigilance on drug portfolio management.
This review examines the influence of pharmacovigilance on drug portfolio. As a result of pharmacovigilance studies, actions are taken by national drug administrations and/or the World Health Organization (WHO) that have a strong impact on drug portfolio management: drug withdrawal from medical practice, discovery of new therapeutic indications, discovery of drug interactions, preference for specific pharmaceutical formulations, discovery of contraindications and change of drug prescription status.